FDA Approves Lilly’s Foundayo Oral GLP-1 Pill The newly approved therapy offers a noninjectable option that can be taken at any time of day without food or water restrictions. By Kathryn Wighton April 1, 2026 2 min Conexiant Share Summary Takeaways Listen Insight Report Clinical Scorecard Quiz Poll Top Thought Leaders